282 related articles for article (PubMed ID: 38542172)
1. The Immunomodulatory Potential of Short-Chain Fatty Acids in Multiple Sclerosis.
Barcutean L; Maier S; Burai-Patrascu M; Farczadi L; Balasa R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542172
[TBL] [Abstract][Full Text] [Related]
2. Serum Short-Chain Fatty Acids and Associations With Inflammation in Newly Diagnosed Patients With Multiple Sclerosis and Healthy Controls.
Olsson A; Gustavsen S; Nguyen TD; Nyman M; Langkilde AR; Hansen TH; Sellebjerg F; Oturai AB; Bach Søndergaard H
Front Immunol; 2021; 12():661493. PubMed ID: 34025661
[TBL] [Abstract][Full Text] [Related]
3. Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.
Shin Y; Han S; Kwon J; Ju S; Choi TG; Kang I; Kim SS
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892541
[TBL] [Abstract][Full Text] [Related]
4. The impact of microbiota-derived short-chain fatty acids on macrophage activities in disease: Mechanisms and therapeutic potentials.
Duan H; Wang L; Huangfu M; Li H
Biomed Pharmacother; 2023 Sep; 165():115276. PubMed ID: 37542852
[TBL] [Abstract][Full Text] [Related]
5. Gut dysbiosis and lack of short chain fatty acids in a Chinese cohort of patients with multiple sclerosis.
Zeng Q; Junli Gong ; Liu X; Chen C; Sun X; Li H; Zhou Y; Cui C; Wang Y; Yang Y; Wu A; Shu Y; Hu X; Lu Z; Zheng SG; Qiu W; Lu Y
Neurochem Int; 2019 Oct; 129():104468. PubMed ID: 31108132
[TBL] [Abstract][Full Text] [Related]
6. Short chain fatty acids, a possible treatment option for autoimmune diseases.
Golpour F; Abbasi-Alaei M; Babaei F; Mirzababaei M; Parvardeh S; Mohammadi G; Nassiri-Asl M
Biomed Pharmacother; 2023 Jul; 163():114763. PubMed ID: 37105078
[TBL] [Abstract][Full Text] [Related]
7. Alterations in Circulating Fatty Acid Are Associated With Gut Microbiota Dysbiosis and Inflammation in Multiple Sclerosis.
Saresella M; Marventano I; Barone M; La Rosa F; Piancone F; Mendozzi L; d'Arma A; Rossi V; Pugnetti L; Roda G; Casagni E; Cas MD; Paroni R; Brigidi P; Turroni S; Clerici M
Front Immunol; 2020; 11():1390. PubMed ID: 32733460
[No Abstract] [Full Text] [Related]
8. The short-chain fatty acids butyrate and propionate protect against inflammation-induced activation of mediators involved in active labor: implications for preterm birth.
Moylan HEC; Nguyen-Ngo C; Lim R; Lappas M
Mol Hum Reprod; 2020 Jun; 26(6):452-468. PubMed ID: 32236411
[TBL] [Abstract][Full Text] [Related]
9. Substrate degradation and postbiotic analysis of alternative fiber ingredients fermented using an in vitro canine fecal inoculum model.
Holt DA; Corsato Alvarenga I; Donadelli RA; Aldrich CG
J Anim Sci; 2023 Jan; 101():. PubMed ID: 36943140
[TBL] [Abstract][Full Text] [Related]
10. Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis.
Moles L; Delgado S; Gorostidi-Aicua M; Sepúlveda L; Alberro A; Iparraguirre L; Suárez JA; Romarate L; Arruti M; Muñoz-Culla M; Castillo-Triviño T; Otaegui D;
Front Immunol; 2022; 13():960761. PubMed ID: 36325343
[TBL] [Abstract][Full Text] [Related]
11. Anticancer Effects of Gut Microbiota-Derived Short-Chain Fatty Acids in Cancers.
Son MY; Cho HS
J Microbiol Biotechnol; 2023 Jul; 33(7):849-856. PubMed ID: 37100764
[TBL] [Abstract][Full Text] [Related]
12. Short-chain fatty acids (SCFAs) alone or in combination regulate select immune functions of microglia-like cells.
Wenzel TJ; Gates EJ; Ranger AL; Klegeris A
Mol Cell Neurosci; 2020 Jun; 105():103493. PubMed ID: 32333962
[TBL] [Abstract][Full Text] [Related]
13. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease.
Wang F; Qian F; Zhang Q; Zhao J; Cen J; Zhang J; Zhou J; Luo M; Jia C; Rong X; Chu M
Front Immunol; 2023; 14():1124118. PubMed ID: 37398673
[TBL] [Abstract][Full Text] [Related]
14. Regulation of CD4
Schiweck C; Edwin Thanarajah S; Aichholzer M; Matura S; Reif A; Vrieze E; Weigert A; Visekruna A
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35955407
[TBL] [Abstract][Full Text] [Related]
15. Short-chain fatty acids in diseases.
Zhang D; Jian YP; Zhang YN; Li Y; Gu LT; Sun HH; Liu MD; Zhou HL; Wang YS; Xu ZX
Cell Commun Signal; 2023 Aug; 21(1):212. PubMed ID: 37596634
[TBL] [Abstract][Full Text] [Related]
16. Benefits of short-chain fatty acids and their receptors in inflammation and carcinogenesis.
Sivaprakasam S; Prasad PD; Singh N
Pharmacol Ther; 2016 Aug; 164():144-51. PubMed ID: 27113407
[TBL] [Abstract][Full Text] [Related]
17. Microbiome changes involves in mercaptopurine mediated anti-inflammatory response in acute lymphoblastic leukemia mice.
Jin S; Xu J; Zou Y; Li X; Yu B; Han J; Wang X; Zhao L
Int Immunopharmacol; 2023 Oct; 123():110782. PubMed ID: 37573688
[TBL] [Abstract][Full Text] [Related]
18. The Short-Chain Fatty Acids Propionate and Butyrate Augment Adherent-Invasive Escherichia coli Virulence but Repress Inflammation in a Human Intestinal Enteroid Model of Infection.
Pace F; Rudolph SE; Chen Y; Bao B; Kaplan DL; Watnick PI
Microbiol Spectr; 2021 Oct; 9(2):e0136921. PubMed ID: 34612688
[TBL] [Abstract][Full Text] [Related]
19. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations.
van de Wouw M; Boehme M; Lyte JM; Wiley N; Strain C; O'Sullivan O; Clarke G; Stanton C; Dinan TG; Cryan JF
J Physiol; 2018 Oct; 596(20):4923-4944. PubMed ID: 30066368
[TBL] [Abstract][Full Text] [Related]
20. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism.
Abdalkareem Jasim S; Jade Catalan Opulencia M; Alexis Ramírez-Coronel A; Kamal Abdelbasset W; Hasan Abed M; Markov A; Raheem Lateef Al-Awsi G; Azamatovich Shamsiev J; Thaeer Hammid A; Nader Shalaby M; Karampoor S; Mirzaei R
Int Immunopharmacol; 2022 Sep; 110():108983. PubMed ID: 35750016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
